US Biosimilar Approvals In 2021 Were Few But Included Many Firsts

 
• By Dave Wallace
  
Biosimilar perspectives 21-22
There are now seven FDA-approved biosimilars for adalimumab (Abbvie's Humira) • Source: Nielsen Hobbs; the Pink Sheet | Alamy image
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics